Clinical trials
Adverse Event clinical trials
Below are recruiting adverse event clinical trials, each written for real people, not researchers. We’re tracking 188 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06318767Recruiting
Foot Blood Flow Measurements to Predict Limb and Heart Events
This study measures how blood flows through your foot using ultrasound to see if it can predict serious problems with your leg or heart in people with severe circulation problems. The goal is to find a simple test that helps doctors decide the best treatment for you.
AmiensAges 18 years+ - NCT07592234Recruiting
Real-time Safety Tracking for Cancer Treatment
This study tests a new way to quickly track side effects during cancer treatment by having patients report problems in real time. The goal is to catch serious side effects early so doctors can help you faster.
Dublin, DublinAges Any age - NCT06204549Recruiting
Managing health issues to lower heart risk
This trial checks if treating other health problems during a hospital stay can help lower your risk of heart disease or stroke. It is for people who either have never had a heart event but have several risk factors, or who have already had a major heart event.
MontpellierAges 18 years+ - NCT05282654Recruiting
Using phone symptom check-ins to prevent problems after discharge
This trial studies a real-time symptom monitoring system (ePROs) that collects your symptoms during care transitions, like when you leave the hospital. The goal is to catch warning signs early so you can avoid adverse events after discharge.
Boston, MassachusettsAges 18 years+ - NCT06915389Recruiting
Gastric cancer: predicting immune therapy side effects
This trial studies whether blood tests before treatment can predict side effects from immunotherapy (PD-1/PD-L1 inhibitors) in people with gastric cancer. If you are about to start this type of treatment, your participation could help doctors manage side effects better.
Xining, QinghaiAges 18–80 - NCT06789601RecruitingPhase 1/Phase 2
Better tracking of immunotherapy side effects study
This trial aims to improve how doctors spot and track side effects from immunotherapy. If you are on or have had immunotherapy, your experience can help build a better system for monitoring these treatments.
Boston, MassachusettsAges Any age - NCT07453342Recruiting
Safety of immunotherapy side effects and restarting treatment
This study looks at patients who had side effects from cancer immunotherapy (checkpoint inhibitors). The goal is to understand those side effects and whether it is safe to restart immunotherapy after they resolve.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06624696RecruitingPhase 4
Inhaled penehyclidine to prevent breathing problems in children having eye surgery
This study tests whether giving a medication called penehyclidine (given as a mist inhaled before surgery) can help prevent breathing problems in children aged 3–7 who are having eye surgery and are at risk for such problems. The medicine is compared to a placebo (a mist with no active drug).
Guangzhou, GuangdongAges 3–7 - NCT07000877RecruitingPhase 4
Nasal spray to help kids with colds during anesthesia
This study tests whether a nasal decongestant spray can help prevent breathing problems during anesthesia for children with a cold. If your child has a recent cold and is having surgery, this could help make the anesthesia safer.
Perth, WeAges 1–8 - NCT05700565Recruiting
Treating hard-to-treat immune side effects after immunotherapy
This trial studies a treatment called ECP to help immune-related side effects (irAEs) that did not improve with standard steroid treatment. It may help control symptoms and change immune activity to reduce ongoing harm from immunotherapy.
MunichAges Any age - NCT07357636Recruiting
Immune therapy side effects study for solid tumors
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
Fuzhou, FujianAges 18 years+ - NCT05813418Recruiting
Finding blood and other clues for immune side effects
This study looks for early “predictive clues” (often blood or test markers) that can forecast immune-related side effects in people treated with immune checkpoint medicines. The goal is to help doctors recognize who may be more likely to have these side effects while receiving treatment.
Amiens, PicardieAges 18 years+ - NCT05212792Recruiting
Study genes after COVID vaccine side effects
This study looks at genetic information to better understand why some people develop serious side effects after a COVID-19 vaccine, such as GBS, blood clotting with low platelets (VITT/TTS), or heart inflammation (myocarditis/pericarditis). Your information may help researchers learn who is at higher risk and improve future safety.
Vancouver, British ColumbiaAges 5–99 - NCT06498167Recruiting
Rinvoq safety study
This study is checking the safety of the medicine Rinvoq (upadacitinib) in people who have been prescribed it. It involves answering a few questions over the phone to help doctors understand how the medicine is working for you.
PortoAges 18 years+ - NCT07554820RecruitingPhase 4
Heart Protection in Rheumatoid Arthritis With New Medications
This study compares two treatment approaches for people with active rheumatoid arthritis who also have heart disease risk factors. It tests whether a newer drug called tofacitinib, combined with cholesterol medication, can better protect the heart than traditional TNF-inhibitor treatments.
Lahore, Punjab ProvinceAges 50–85 - NCT07164300Recruiting
Tranexamic acid dosing study in heart surgery
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
IoanninaAges 18–99 - NCT05192876Recruiting
Review of outcomes and side effects during radiation treatment
This study collects information about results and side effects from people receiving radiation therapy at a specific hospital. It may help improve how radiation treatment is planned and monitored in the future.
Winterthur, Canton of ZurichAges 16–105 - NCT06108414RecruitingPhase 4
Low-dose vs standard-dose blood thinner for older adults with atrial fibrillation
This trial tests whether a lower dose of the blood thinner rivaroxaban works as well as the standard dose for people 70 and older with atrial fibrillation (an irregular heartbeat). The goal is to find the safest dose to prevent strokes while reducing bleeding risks.
Beijing, Beijing MunicipalityAges 70 years+ - NCT05804188Recruiting
Testing safer breathing tube care in intubated children
This trial studies care during placing a breathing tube (tracheal intubation) in children having general anesthesia. It may help improve safety and outcomes around the breathing tube process.
Boston, MassachusettsAges Up to 16 years - NCT05800054Recruiting
Nutrition support program for people with esophageal cancer
This trial tests whether an “NST whole-course” nutrition management plan can improve nutrition status and reduce side effects during treatment for stage II–III esophageal cancer. It may help you stay stronger and tolerate cancer therapy better by carefully monitoring and adjusting nutrition.
Nanjing, JiangsuAges 18–75 - NCT05799898Recruiting
Fast heart and vessel check for people on immune cancer drugs
This trial looks at a faster heart and blood-vessel assessment for people who are taking immune cancer drugs and have been referred because they might be having a heart-related side effect. It may help by speeding up evaluation and treatment decisions when symptoms raise concern.
ParisAges 18 years+ - NCT06467045Recruiting
Sedation side effects in children having MRI
This study tracks side effects of sedation in children getting an MRI. It helps doctors understand what to expect and how to keep kids safe during the scan.
Istanbul, SarıyerAges birth–16 years - NCT07000357RecruitingPhase 3
Study of AZD0780 to reduce heart attack and stroke risk
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
Athens, AlabamaAges 18 years+ - NCT07004452Recruiting
Predicting heart risks in younger adults with early heart disease
This study uses a multi-modal approach to predict adverse events in adults aged 18-45 with premature coronary heart disease. It aims to improve risk prediction and management for younger patients.
BeijingAges 18–45
Hear when a new Adverse Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adverse event?
- Yes. Clin2 currently lists 188 recruiting adverse event studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adverse event trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adverse event trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.